Although HCC patients with either elevated AFP or elevated DCP before HAIC were included in this study, we defined a non-response with respect to these markers both as a reduction of < 20% from baseline and an increase from baseline after half a course of HAIC. The gene discussed is ACE; the disease is hepatocellular carcinoma.